Skip to main content Help with accessibility Skip to main navigation

MESALAZINE oral formulations

CCG Approval Status:

Date Added: 28 - Feb - 2018
Amber initiated

The Pan Mersey Area Prescribing Committee recommends the prescribing of Mesalazine oral formulations by brand name following specialist initiation for inflammatory bowel disease. Octasa® brand is considered to be equivalent to Asacol® brand and currently represents a more cost effective choice.